ABL Bio-Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 12	Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08

Sources of funds

Owner's fund

Equity share capital

8.20

8.20

8.20

8.20

4.10

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6.57

6.75

7.35

28.23

4.73

Loan funds

Secured loans

4.31

4.31

4.37

5.32

4.18

Unsecured loans

12.79

12.65

12.29

11.27

9.97

Total

31.88

31.92

32.21

53.02

22.98

Uses of funds

Fixed assets

Gross block

34.80

34.86

35.98

8.98

8.96

Less : revaluation reserve

3.79

3.79

3.79

3.79

3.79

Less : accumulated depreciation

-

-

0.88

1.56

1.37

Net block

31.02

31.07

31.31

3.64

3.80

Capital work-in-progress

-

-

-

7.62

7.34

Investments

1.31

1.30

1.30

1.30

1.30

Net current assets

Current assets, loans & advances

8.98

9.07

8.77

48.38

17.92

Less : current liabilities & provisions

9.43

9.53

9.60

8.88

7.84

Total net current assets

-0.45

-0.46

-0.83

39.50

10.08

Miscellaneous expenses not written

-

-

0.43

0.95

0.45

Total

31.88

31.92

32.21

53.02

22.98

Notes:

Book value of unquoted investments

1.31

1.30

1.30

1.30

1.30

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

4.52

4.52

1.91

1.91

-

Number of equity sharesoutstanding (Lacs)

82.00

82.00

82.00

82.00

41.00